• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用一种 QC 就绪的游离脂肪酸定量方法监测生物制药中的聚山梨酯水解。

Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method.

机构信息

F. Hoffmann-La Roche, Grenzacherstrasse 124, 4070 Basel, Switzerland.

Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 15;1116:1-8. doi: 10.1016/j.jchromb.2019.03.030. Epub 2019 Mar 26.

DOI:10.1016/j.jchromb.2019.03.030
PMID:30951966
Abstract

Hydrolysis of the non-ionic surfactant polysorbate upon long-term storage poses significant challenges to development of biopharmaceutical liquid formulations. Low concentrations of intact surfactant may compromise its protective properties and thus affect protein stability. In addition, accumulation of polysorbate hydrolysis products is increasingly put into context with the formation of visible and subvisible particulates based on the low solubility of the main degradation products. Despite of this potential negative impact on product quality, quantification of the released free fatty acids is performed commonly in an indirect and consequently insensitive manner by determining the remaining PS content or by cumbersome methods, which are unsuitable for routine testing in quality control laboratories. For this purpose, this study describes the development and qualification of a label-free, reliable liquid-chromatography single quad mass detector (LC-QDa)-based method capable of resolving slight changes in the free fatty acid profile which can be readily integrated into quality control facilities. The practical utility of the herein described method is outlined by a case study on the real-time storage stability of a formulated monoclonal antibody.

摘要

非离子表面活性剂聚山梨酯在长期储存过程中的水解对生物制药液体制剂的开发构成了重大挑战。低浓度的完整表面活性剂可能会破坏其保护性能,从而影响蛋白质稳定性。此外,基于主要降解产物的低溶解度,聚山梨酯水解产物的积累与可见和亚可见颗粒的形成越来越相关。尽管如此,由于释放的游离脂肪酸的定量分析通常是通过间接的、因此不敏感的方法来进行的,即通过测定剩余的 PS 含量或繁琐的方法来进行,这些方法不适合质量控制实验室的常规测试。为此,本研究描述了一种无标记、可靠的基于液相色谱单四级杆质量检测器(LC-QDa)的方法的开发和验证,该方法能够分辨游离脂肪酸谱的细微变化,可方便地整合到质量控制设施中。通过对单克隆抗体配方实时储存稳定性的案例研究,概述了本文所述方法的实际应用。

相似文献

1
Monitoring polysorbate hydrolysis in biopharmaceuticals using a QC-ready free fatty acid quantification method.使用一种 QC 就绪的游离脂肪酸定量方法监测生物制药中的聚山梨酯水解。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 15;1116:1-8. doi: 10.1016/j.jchromb.2019.03.030. Epub 2019 Mar 26.
2
Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism.生物制药制剂中聚山梨醇酯20的降解:游离脂肪酸的定量、颗粒的表征及降解机制的深入研究
Mol Pharm. 2015 Nov 2;12(11):3805-15. doi: 10.1021/acs.molpharmaceut.5b00311. Epub 2015 Oct 13.
3
A Rapid High-Sensitivity Reversed-Phase Ultra High Performance Liquid Chromatography Mass Spectrometry Method for Assessing Polysorbate 20 Degradation in Protein Therapeutics.一种快速高灵敏度反相超高效液相色谱质谱法评估蛋白质治疗药物中聚山梨酯 20 降解。
J Pharm Sci. 2019 Sep;108(9):2880-2886. doi: 10.1016/j.xphs.2019.04.029. Epub 2019 May 2.
4
Controlled polysorbate 20 hydrolysis - A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time.控制聚山梨酯 20 水解——一种在更短时间内评估聚山梨酯 20 降解对生物制药产品质量影响的新方法。
Eur J Pharm Biopharm. 2020 Jul;152:318-326. doi: 10.1016/j.ejpb.2020.05.017. Epub 2020 May 20.
5
Improving Prediction of Free Fatty Acid Particle Formation in Biopharmaceutical Drug Products: Incorporating Ester Distribution during Polysorbate 20 Degradation.提高生物制药制剂中游离脂肪酸粒子形成预测的准确性:在聚山梨酯 20 降解过程中考虑酯分布。
Mol Pharm. 2020 Nov 2;17(11):4354-4363. doi: 10.1021/acs.molpharmaceut.0c00794. Epub 2020 Oct 8.
6
Development and validation of a selective marker-based quantification of polysorbate 20 in biopharmaceutical formulations using UPLC QDa detection.开发并验证了一种基于选择性标记的 UPLC QDa 检测法,用于生物制药制剂中聚山梨酯 20 的定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Nov 10;1157:122287. doi: 10.1016/j.jchromb.2020.122287. Epub 2020 Jul 31.
7
Hydrolytic polysorbate 20 degradation - Sensitive detection of free fatty acids in biopharmaceuticals via UPLC-QDa analytics with isolator column.水解聚山梨酯 20 降解-通过隔离器柱 UPLC-QDa 分析灵敏检测生物制药中的游离脂肪酸。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jun 1;1174:122717. doi: 10.1016/j.jchromb.2021.122717. Epub 2021 Apr 21.
8
Characterization of Polysorbate Ester Fractions and Implications in Protein Drug Product Stability.聚山梨酯酯级分的特性及其对蛋白药物产品稳定性的影响。
Mol Pharm. 2020 Jul 6;17(7):2345-2353. doi: 10.1021/acs.molpharmaceut.0c00093. Epub 2020 Jun 5.
9
High throughput FAMS - A fatty acid mass spectrometry method for monitoring polysorbate hydrolysis in QC.高通量脂肪酸甲酯化谱分析法——一种用于在质量控制中监测聚山梨醇酯水解的脂肪酸质谱分析法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Apr 1;1220:123614. doi: 10.1016/j.jchromb.2023.123614. Epub 2023 Jan 27.
10
Monitoring polysorbate hydrolysis in therapeutic proteins using an ultrasensitive extraction-free fatty acid quantitation method.采用超灵敏非提取游离脂肪酸定量法监测治疗性蛋白中聚山梨酯的水解。
Anal Biochem. 2022 Jan 15;637:114472. doi: 10.1016/j.ab.2021.114472. Epub 2021 Nov 18.

引用本文的文献

1
FAMS-A Targeted Fatty Acid Mass Spectrometry Method for Monitoring Free Fatty Acids from Polysorbate Hydrolysis.FAMS-A:一种用于监测聚山梨酯水解产生的游离脂肪酸的靶向脂肪酸质谱分析法。
Methods Protoc. 2024 Sep 7;7(5):71. doi: 10.3390/mps7050071.
2
Prediction of long-term polysorbate degradation according to short-term degradation kinetics.根据短期降解动力学预测聚山梨酯的长期降解情况。
MAbs. 2023 Jan-Dec;15(1):2232486. doi: 10.1080/19420862.2023.2232486.
3
Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control.
基于质谱的蛋白质治疗药物产品质量监测和质量控制的多属性方法。
MAbs. 2023 Jan-Dec;15(1):2197668. doi: 10.1080/19420862.2023.2197668.
4
Alternative Excipients for Protein Stabilization in Protein Therapeutics: Overcoming the Limitations of Polysorbates.蛋白质治疗药物中用于蛋白质稳定化的替代辅料:克服聚山梨酯的局限性
Pharmaceutics. 2022 Nov 23;14(12):2575. doi: 10.3390/pharmaceutics14122575.